American Association for Cancer Research (AACR)

Cancer is not a single disease, but rather a collection of diseases all characterized by the uncontrolled proliferation of cells.

Unprecedented, research-driven advances in cancer immunology over the past two decades have firmly established immunotherapy as the fifth pillar of cancer medicine.

Nearly 159,000 people in the United States are expected to be diagnosed with colorectal cancer last year. Read about colorectal cancer prevention, screening, and treatment options.

Boosting the Immune Response to Cancer: Decades of pioneering research led to a first-of-its-kind FDA approval for a new type of immunotherapy—tumor-infiltrating lymphocyte (TIL) therapy.

Useful information for cancer patients and their families, survivors, caregivers, advocates, and others from Cancer Today magazine.

Whether honoring a special person or a special day, a donation to the American Association for Cancer Research has a lasting impact.